IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer On ...

Toxicity related to the systematic delivery of IL-12, a well-known and widely researched anti-tumor cytokine, has limited its ...

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell ...

For example, using this advanced technology, researchers developed an IL-12 immunotherapy called IMNN-001 that uses a DNA plasmid vector encased in a nanoparticle delivery system to deliver IL-12 ...

A second phase 1 trial plans to evaluate CER-1236, a novel chimeric antigen receptor therapy, for solid tumors.

[212Pb]VMT01 is being tested in combination with Opdivo in a phase 1/2a trial for melanoma patients with positive MC1R imaging scans. The FDA granted fast track designation to [212Pb]VMT01 for ...

Heartseed Inc. and Novo Nordisk - in partnership since June 2021 - have announced that the first patient has been successfully dosed in a clinical study with HS-001, a cell therapy designed to ...